Skip to main content

Zai Lab Ltd

ZLAB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001704292

In the last 90 days, Zai Lab Ltd insiders filed 1 open-market purchase and 4 sales; 92 institutions reported holding it in 13F filings for Q2 2026, worth $819.0M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Zai Lab Ltd changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of ZLAB: Q2 2023 compared with Q3 2023
MeasureQ2 2023Of which not filed for Q3 2023Q3 2023Change
Holders1381122−15
Shares42.8M232.2K39.4M−3.15M (−7.4%)
Value$1.19B$6.44M$954.6M−$224.5M (−19.0%)

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (12)

Institutions that held Zai Lab Ltd at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to ZLAB in Q3 2023
InstitutionSharesValue% of portfolio
Pictet Asset Management Holding SA239,576$5.82M0.01%
Brilliance Asset Management Ltd157,085$3.82M0.96%
XY Capital Ltd139,743$3.40M3.11%
Capricorn Fund Managers Ltd100,967$2.45M0.85%
HRT Financial LP89,923$2.19M0.02%
Nomura Holdings Inc48,067$1.17M0.01%
Lansdowne Partners (UK) LLP35,142$854.3K0.08%
Millennium Management LLC24,611$598.3K0.00%
LMR Partners LLP19,030$462.6K0.01%
Voloridge Investment Management, LLC10,614$258.0K0.00%
Wells Fargo & Company141$3.43K0.00%
Sands Capital Management, LLC98$2.38K0.00%

Sold out (27)

Institutions that held Zai Lab Ltd at the end of Q2 2023 and filed for Q3 2023 without it.

Not filed for Q3 2023 yet (1)

Institutions that held Zai Lab Ltd at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ZLAB in Q2 2023 that haven't filed for Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Pictet Asset Management SA232,210$6.44M